Dr. Scott E. Brodie, MD

Dr. Brodie practices at Trustees of Columbia University in the City of New York in Fort Lee, New Jersey.

Dr. Brodie's NPI, 1134128465, was assigned on July 19, 2005. Dr. Brodie graduated from Weill Cornell Medicine in 1980. Dr. Brodie holds New York license 146372.

Dr. Brodie's primary practice is Trustees of Columbia University in the City of New York, at 400 Kelby St, Fort Lee, NJ 07024 in Bergen County. The practice phone is (646) 317-7111.

Dr. Brodie's primary practice is Trustees of Columbia University in the City of New York in Fort Lee, New Jersey. The medical group on file is Mount Sinai Institute for Liver Medicine. Dmand AI also links Dr. Brodie to 3 more group practices and clinics and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Brodie practices, 3 sites in all. Vendor and product names are available with a free account.

Ophthalmology is Dr. Brodie's primary specialty in the NPI Registry, under taxonomy code 207W00000X. Dr. Brodie is board certified in ophthalmology by the American Board of Ophthalmology. Dr. Brodie is licensed in New York.

Dmand AI lists age-related macular degeneration, glaucoma and vision problems among the conditions Dr. Brodie treats.

CMS data shows 232 Medicare services from Dr. Brodie across 7 procedure codes in 2024, for 104 Medicare patients. Medicare paid $17,821 for them. Every service was in an office.

CMS counts 104 Medicare patients who saw Dr. Brodie in 2024. The largest group is 75 to 84, with 45 patients. 75% of them have high cholesterol, and 64% have high blood pressure. 13% are also on Medicaid. Their average risk score is 1.25, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Brodie's median patient age at 51, with 51% women.

In 2022, Dr. Brodie wrote 41 Medicare Part D claims. Every claim was for a generic drug. They cover 1 drug, with $704 in total drug cost. In 2021, CMS named 43 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Brodie for performance year 2024, reported through an alternative payment model (APM). Dr. Brodie accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 138 papers to Dr. Brodie, published from 2001 to 2025. 2018 was the busiest year, with 7. The most frequent topics are Retinoblastoma, Electroretinography and Retinal Neoplasms. Dr. Brodie has published most often in Doc Ophthalmol. Dr. Brodie's most frequent co-authors are Brian P. Marr, MD, Jasmine H. Francis, MD and Ira J. Dunkel, MD.

Dmand AI links Dr. Brodie to 1 clinical trial. Conditions studied include Macular Edema and Macular Degeneration.

CMS Open Payments shows 10 general payments to Dr. Brodie from 4 drug and device companies from 2016 to 2021. Speaker and faculty fees make up the largest share, 79% of the total. Sanofi and Genzyme US Companies paid the most, $5,897.

Dmand AI lists 1 award for Dr. Brodie.

Dr. Brodie graduated from Weill Cornell Medicine in 1980. Dr. Brodie is a member of AAO.

Dr. Brodie is in network with 14 carriers, including Aetna, Elevance and Excellus BlueCross BlueShield. Medicare plans come from the most carriers, 11. Check the plan with the practice before a visit.